Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

July 01, 2011 (Vol. 31, No. 13)

Alleviating Downstream Process Bottlenecks

Industry Demands Better Technologies as Logjams Weigh Down Manufacturing Operations

  • Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create these constraints. As shown in our 8th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, industry concerns over downstream processing, ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.